The stock symbol for Edgewise Therapeutics common stock is EWTX and the CUSIP number is 28036F 10 5.
Edgewise Therapeutics went public on March 26, 2021.
Edgewise Therapeutics common stock is traded on the NASDAQ Global Select Market.
Edgewise Therapeutics was incorporated in Delaware in 2017.
Edgewise Therapeutics’ independent auditors are KPMG LLP.
Edgewise Therapeutics has not paid a dividend to date.
Broadridge is our transfer agent. Their contact information follows: Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, NY 11717 Phone: 1-844-998-0339 and 303-562-9304 Website: shareholder.broadridge.com Email: shareholder@broadridge.com
Edgewise Therapeutics does not have a direct stock purchase plan. Shares may be purchased through a financial services provider of your choice.
Click here to view our investor contact information.
Click here to view our documents filed with the SEC.